Divalproex Sodium Tablet, Delayed Release
Product Images NDC 71610-031

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 71610-031). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Bottle Label 250mg (71610 031 60)

Bottle Label 250mg (71610 031 60)
This is a medication called "Divalproex Sodium Delayed-Release" that comes in the form of 250mg tablets packaged in a bottle with 90 tablets. The NDC number provided is 715100180.*
FDA Label Image

Aphena Pharma Solutions (TN)

Aphena Pharma Solutions (TN)
FDA Label Image

Chemical Structure (Divalproex 01)

Chemical Structure (Divalproex 01)
FDA Label Image

Figure 1 (Divalproex 02)

Figure 1 (Divalproex 02)
This appears to be a table displaying percentage values for two studies and two sets of measures: YMRS (Young Mania Rating Scale) and MRS (Montgomery-Asberg Depression Rating Scale). However, without additional context, it is not possible to provide a full description or interpretation of the data.*
FDA Label Image

Figure 2 (Divalproex 03)

Figure 2 (Divalproex 03)
The text describes a comparison between two drugs, Divalproex sodium delayed-release tablets USP and Placebo. The only metric provided is the "% Reduction In CPS Rate," which is not clear what it refers to.*
FDA Label Image

Figure 3 (Divalproex 04)

Figure 3 (Divalproex 04)
The text represents a table showing the percentage reduction in CPS rate for high and low doses. The table also indicates the percentage of patients experiencing improvement, no change, or worsening in their condition.*
FDA Label Image

Figure 4 (Divalproex 05)

Figure 4 (Divalproex 05)
The text is not useful as it consists of only medication names and study numbers, with misspelled words and signs of errors.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.